[go: up one dir, main page]

DE60322727D1 - Rückgefaltetes Membranprotein in monodisperser Form - Google Patents

Rückgefaltetes Membranprotein in monodisperser Form

Info

Publication number
DE60322727D1
DE60322727D1 DE60322727T DE60322727T DE60322727D1 DE 60322727 D1 DE60322727 D1 DE 60322727D1 DE 60322727 T DE60322727 T DE 60322727T DE 60322727 T DE60322727 T DE 60322727T DE 60322727 D1 DE60322727 D1 DE 60322727D1
Authority
DE
Germany
Prior art keywords
membrane protein
refolded
monodisperse form
monodisperse
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60322727T
Other languages
English (en)
Inventor
Lars Dr Linden
Stefan Dr Prytulla
Thomas Dr Ostermann
Monika Dr Baehner
Tilmann Dr Roos
Andreas Dr Thess
Hans Dr Kiefer
Wolfgang Dr Vogt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
M Phasys GmbH
Original Assignee
M Phasys GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M Phasys GmbH filed Critical M Phasys GmbH
Application granted granted Critical
Publication of DE60322727D1 publication Critical patent/DE60322727D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60322727T 2003-12-15 2003-12-15 Rückgefaltetes Membranprotein in monodisperser Form Expired - Fee Related DE60322727D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03028803A EP1544209A1 (de) 2003-12-15 2003-12-15 Rückgefaltetes Membranprotein in monodisperser Form
US10/736,448 US20050130260A1 (en) 2003-12-15 2003-12-15 Refolded membrane protein in monodisperse form

Publications (1)

Publication Number Publication Date
DE60322727D1 true DE60322727D1 (de) 2008-09-18

Family

ID=34809734

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60322727T Expired - Fee Related DE60322727D1 (de) 2003-12-15 2003-12-15 Rückgefaltetes Membranprotein in monodisperser Form

Country Status (6)

Country Link
US (1) US20050130260A1 (de)
EP (3) EP1550669B1 (de)
JP (1) JP2007537139A (de)
AT (1) ATE403670T1 (de)
DE (1) DE60322727D1 (de)
WO (1) WO2005058942A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060046962A1 (en) * 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
US20090047347A1 (en) * 2005-07-29 2009-02-19 Aegis Therapeutics, Inc. Compositions for Drug Administration
US20140162965A1 (en) 2004-08-25 2014-06-12 Aegis Therapeutics, Inc. Compositions for oral drug administration
US8268791B2 (en) * 2004-08-25 2012-09-18 Aegis Therapeutics, Llc. Alkylglycoside compositions for drug administration
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
WO2007139471A2 (en) * 2006-05-31 2007-12-06 Ge Healthcare Bio-Sciences Ab Method for chromatography
US8226949B2 (en) * 2006-06-23 2012-07-24 Aegis Therapeutics Llc Stabilizing alkylglycoside compositions and methods thereof
JP5142267B2 (ja) * 2008-03-04 2013-02-13 独立行政法人産業技術総合研究所 短鎖両性界面活性剤
CA2756690C (en) 2008-03-28 2016-08-16 Hale Biopharma Ventures, Llc Administration of benzodiazepine compositions
US8440631B2 (en) 2008-12-22 2013-05-14 Aegis Therapeutics, Llc Compositions for drug administration
DK3415139T3 (da) 2011-06-14 2022-06-20 Neurelis Inc Administration af benzodiazepin
WO2014125955A1 (ja) 2013-02-15 2014-08-21 国立大学法人京都工芸繊維大学 抗体のリフォールディング方法、リフォールディングされた抗体の製造方法、リフォールディングされた抗体、及びこれらの利用
FR3020070B1 (fr) * 2014-04-22 2018-11-02 Universite Grenoble Alpes Proteines nadph oxydases
CN108753753B (zh) * 2018-05-28 2022-04-22 中国林业科学研究院林业研究所 Lrr受体激酶-pxy的纯化方法
CN110292916B (zh) * 2019-06-26 2020-11-03 中国科学院过程工程研究所 一种磷脂纳米盘层析介质及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9700566D0 (sv) * 1997-02-18 1997-02-18 Pharmacia & Upjohn Ab Modified proteins
AUPP380498A0 (en) * 1998-05-29 1998-06-25 Biomolecular Research Institute Limited Egf receptor agonists and antagonists
US7087729B1 (en) * 1999-06-29 2006-08-08 University Health Network Peptide conjugates for the stabilization of membrane proteins and interactions with biological membranes
DE19939246A1 (de) * 1999-08-19 2001-02-22 Phasys Gmbh M Rückfaltung von Membranproteinen
AU4259901A (en) * 2000-03-28 2001-10-08 Cambridge University Technical Services Limited Receptor/peptide crystal structure for identification of inhibitors
US7235367B2 (en) * 2000-07-12 2007-06-26 Genetics Institute, Llc. Method using crystal structure of estrogen receptor-β complex
EP1409127A2 (de) * 2000-10-24 2004-04-21 Fatemeh Mojtabai Geordnete zwei- und dreidimensionale strukturen aus amphiphilen molekülen

Also Published As

Publication number Publication date
EP1704163A1 (de) 2006-09-27
JP2007537139A (ja) 2007-12-20
EP1544209A1 (de) 2005-06-22
EP1550669B1 (de) 2008-08-06
US20050130260A1 (en) 2005-06-16
WO2005058942A1 (en) 2005-06-30
ATE403670T1 (de) 2008-08-15
EP1550669A1 (de) 2005-07-06
WO2005058942A8 (en) 2006-08-03

Similar Documents

Publication Publication Date Title
DE60322727D1 (de) Rückgefaltetes Membranprotein in monodisperser Form
ATE446313T1 (de) Muteine von tränen-lipocalin
DE60325188D1 (de) Verfahren zur herstellung von sterilen, stabilisierten nanodispersionen
IL172512A0 (en) Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them
WO2004048517A3 (en) Method for reducing or preventing modification of a polypeptide in solution
GB0327380D0 (en) Method
DK1519944T3 (da) Fremgangsmåder til fremstilling af fibrinogen
ATE551069T1 (de) Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
WO2007075438A3 (en) Polypeptides comprising unnatural amino acids, methods for their production and uses therefor
EP1489188A4 (de) Reaktionslösung für zellfreie proteinsynthese, verfahren zur herstellung davon und proteinsyntheseverfahren unter verwendung davon
IL172729A0 (en) Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins
DE60222759D1 (de) Proteinsyntheseverfahren mit zellfreiem proteinsynthesesystem
ITMI20022704A1 (it) Procedimento per la produzione di mesitilene e durene.
BRPI0507886A (pt) método de purificação de albumina compreendendo uma etapa de nanofiltração, solução e composição para uso terapêutico contendo-o
DE60336822D1 (de) Verfahren zur herstellung von kristallinem 1,2-polybutadien
DE60210778D1 (de) Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen
ATE374757T1 (de) Verfahren zur herstellung von (1,4,5)- oxadiazepinderivaten
NO20060535L (no) Aztreonam-L-lysin og fremgangsmater for fremstilling av dette
ATE550345T1 (de) Sfrp, mit sfrp-interagierende peptidmotive sowie verwendungsverfahren
WO2005037191A3 (en) Expression of dominant negative transmembrane receptors in the milk of transgenic animals
WO2004020452A3 (en) Method for refolding neisserial nspa protein
WO2004020416A3 (de) Substituierte pyridine oder pyrimidine, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als schädlingsbekämpfungsmittel
AU2002328285A1 (en) Method for producing an essentially chlorite-free, stable, aqueous chlorine-oxygen solution, the chlorine-oxygen solution obtained by means of said method, and the use of the same
AU2003268706A1 (en) PROCESS FOR PRODUCING OPTICALLY ACTIVE Alpha-SUBSTITUTED CYSTEINE OR SALT THEREOF, INTERMEDIATE THEREFOR, AND PROCESS FOR PRODUCING THE SAME
NO20064057L (no) Metode for a stimulere harvekst

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee